Welcome to to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

July 31, 2015

Irish standardised tobacco packs less attractive than EU versions

New Irish research published in BMJ Open has found that young people aged 16-17 years old believe standardised packs to be less attractive and their cigarettes to be more harmful than packs with EU Tobacco Products Directive (TPD) labels, which includes picture and text warning covering 65 per cent of the packages.

Natural lithium in water may help explain suicide figures

New research from Austria has found no evidence that lithium-based pharmaceuticals either directly or via accumulation in drinking water diminish the risk of death by suicide.

Image-guided biopsies tested against ultrasound approach

In the largest prospective study to date of image-guided technology for identifying suspicious regions of the prostate to biopsy, researchers compared the ability of this technology to detect high-risk prostate cancer with that of the current standard of unguided prostate biopsy.

Biomarkers ‘can select patients’

In the years to come, personalised medicine will be the goal, Gary Culliton reports in his latest Clinical Update. It is a promising area: now much effort is devoted to studying combinations of different therapies.

New approach to early treatments

Colorectal cancer is a treatable disease and there are a number of effective options available. Progress has been made in diagnosing the disease earlier. Data on which treatment works best in the early stages of the cancer is now being sought.

‘Precision medicine’ is now key

Bowel cancer survival has more than doubled in the last 40 years. But much work remains. Key partners have come together to develop new ways to tailor treatment to the patients who will benefit the most, and to make a difference to their chances of beating this common disease.

Primary care proven to ease NCD burden

An analysis of a major integrated primary healthcare programme in Mexico has shown that significant reductions in mortality rates may be explained by both changes in incidence rates and changes in case fatality rates associated with early detection and treatment.

‘Sit-to-stand desks’ may address pupils’ health issues

Pilot studies in UK and Australian primary schools has suggested that the introduction of so-called ‘sit-to-stand desks’ appears to be an effective way of reducing classroom sitting and tackling children’s sedentary behaviour.

A better understanding of resistance sought

Clearly, not every prostate cancer patient will benefit from novel endocrine treatments, Gary Culliton reports in his latest Clinical Update. Thus, personalised medicine is key. The challenge now is to identify which patients will benefit from the drugs and which will not.

Cruinn Diagnostics is proud to launch the new Xprecia Stride analyser in partnership with Siemens Healthcare Diagnostics.

So small, it can fit in your pocket. So accurate, it could go in a lab. The new Xprecia Stride Coagulation Analyzer brings accuracy to the point of care.

Next Page »